Metacognitive impairment in patients with episodic and chronic migraine

J Clin Neurosci. 2020 Feb:72:119-123. doi: 10.1016/j.jocn.2019.12.048. Epub 2020 Jan 3.

Abstract

Migraine is one of the most common medical disorder in the world. Metacognition is the ability to monitor one's own cognitive functioning and consequently direct one's behavior. In adult migraine patients, the neuropsychological profile has been poorly investigated, and metacognitive functions have never been assessed. The aim of the present study was therefore to evaluate executive metacognitive abilities in patients with episodic and chronic migraine. Sixty-four migraine patients (male/female = 18/46; mean age = 45.65 ± 11.61 years): 27 patients with episodic migraine without aura (male/female = 9/18; mean age ± SD = 45.11 ± 12.18 years) and 37 patients with chronic migraine and medication-overuse headache (male/female = 9/28; mean age ± SD = 46.05 ± 11.32 years) were selected for the study. Twenty-nine controls (male/female = 12/17; mean age ± SD = 42.86 ± 14.78 years) were also enrolled in the research. Metacognitive and executive skills were assessed using the metacognitive version of Wisconsin Card Sorting Test. Migraine patients exhibited a lower performance in metacognitive tasks in respect to controls in term of worse outcomes in accuracy score (p = 0.012), global monitoring (p = 0.015), monetary gains (p = 0.022), and control sensitivity (p = 0.027). A reduction in accuracy score (p = 0.001), free-choice improvement (p = 0.002), global monitoring (p = 0.003), monetary gains (p = 0.009), and control sensitivity (p < 0.001) was also found in patients with chronic migraine and medication-overuse headache in respect to patients with episodic migraine. Our study supports the hypothesis that migraine patients show metacognitive dysfunctions that become worse with the chronicization of the disease and the increase of medication use.

Keywords: Executive functions; Medication-overuse headache; Metacognition; Migraine; Wisconsin card sorting test.

MeSH terms

  • Adult
  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects
  • Chronic Disease
  • Cognition / drug effects
  • Cognition / physiology
  • Female
  • Headache Disorders, Secondary / diagnosis
  • Headache Disorders, Secondary / psychology
  • Humans
  • Male
  • Metacognition / drug effects
  • Metacognition / physiology*
  • Middle Aged
  • Migraine Disorders / diagnosis*
  • Migraine Disorders / drug therapy
  • Migraine Disorders / psychology*
  • Serotonin Receptor Agonists / adverse effects
  • Wisconsin Card Sorting Test

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Serotonin Receptor Agonists